HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NBTY Internet Business To Play Prominent Role In Direct Sales

This article was originally published in The Tan Sheet

Executive Summary

NBTY's Internet operations continue to grow and will play a prominent role in the company's direct sales strategy, Chairman and CEO Scott Rudolph told securities analysts during a conference call Jan. 27.

You may also be interested in...



NBTY Puritan.com TV Ad Campaign Aims To Attract 200,000 New Customers

NBTY hopes a $5 mil. cable TV advertising campaign for the Puritan's Pride Web site will generate 200,000 to 300,000 new customers for what the supplement manufacturer says is the "largest direct-to-the-consumer vitamin brand," with 6 mil. customers and 15,000 orders processed daily.

NBTY Nutrition Warehouse Acquisition Adds To Direct Mail, Retail Growth

NBTY has reached an agreement to acquire the vitamin and supplement firm Nutrition Warehouse, Inc. for $20 mil. and just over 1 mil. shares of NBTY stock, the company announced Nov. 12.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133562

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel